Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

investors.com/news/technology/novartis-stock-novartis-earnings-q4-2024/?src=A00220

stock edged higher early Friday after the pharma giant reported core earnings of $1.98 per share on $13.15 billion in fourth-quarter sales.
↑ X How To Buy Stocks: IBD's Four Pillars Of InvestingAnalysts polled by FactSet expected Novartis to earn $1.80 per share on $12.84 billion in…

This story appeared on investors.com, 2025-01-31 13:55:44.
The Entire Business World on a Single Page. Free to Use →